Pre-treatment with oral hydroxyurea prior to intensive chemotherapy improves early survival of patients with high hyperleukocytosis in acute myeloid leukemia
Anne‐Claire Mamez(Délégation Paris 7), Étienne Lengliné(Assistance Publique – Hôpitaux de Paris), Sylvie Chevret(Saint Louis University Hospital), Emmanuel Raffoux(Inserm), Élie Azoulay(Hôpital Saint-Louis), Nicolas Boissel(Inserm), Virginie Lemiale(Assistance Publique – Hôpitaux de Paris), Hervé Dombret(University of London Institute in Paris), Benoı̂t Schlemmer(Université Paris Cité), Emmanuel Canet(Centre Hospitalier Universitaire de Nantes)
Cited by 48
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k